• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Air Embolism (1697); Non specific EKG/ECG Changes (1817); Hypoxia (1918); Diminished Pulse Pressure (2606); Heart Block (4444)
Event Date 04/08/2024
Event Type  Death  
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
It was reported that air embolism and death occurred.The procedure was cancelled.During a watchman left atrial appendage closure (laac), a versacross connect access solution kit was selected for use.The patient was placed under conscious sedation by a staff registered nurse (rn).Bilateral venous femoral access was obtained.Intracardiac echocardiography (ice) imaging catheter was inserted in one access site and a watchman sheath (was) was inserted via the other access site.Ice was used to visualize the septum for transseptal (tsp) access.Versacross connect was used to successfully complete tsp through the was (mid-inferior) and mid ap approach successfully.The was sheath passed through the septum into the left atrium (la) without difficulty, and the versacross rf wire was noted to be in the left upper pulmonary vein.Thus, the patient began to snore loudly where the nurse noted agonal breathing and poor skin color, suggesting poor oxygenation.An oxygen mask was placed on the patient in an attempt to improve oxygenation.Second prior to this, the hemostasis valve on the watchman sheath was opened to remove the versacross dilator, and the physician visualized air bubbles, noted on ice.At this point, the patient's oxygenation had not improved, and a st segment elevation and atrioventricular (av) heart block were noted.The watchman sheath was pulled back to the right atrium and the versacross rf wire was removed from the la.The patient lost pulses and chest compressions were initiated (code was called).The patient was intubated by anesthesia and despite advanced cardiac life support (acls) resuscitation efforts, the patient died.The procedure was cancelled.The device is not available for analysis.The official cause of death was noted to be probable hypoxia due to air embolism.In the physician's opinion, there was a possibility of air entering the was sheath as the versacross dilator was removed as the was sheath hemostasis valve was opened, as simultaneously the patient was snoring with long pauses observed in breathing rhythm, and with agonal breathing, and additionally the versacross devices did not contributed to patient complications.It was further confirmed that no difficulties were encountered during the transseptal puncture, and no air was visualized prior to removing the versacross dilator from the was sheath.There were no versacross devices malfunctions reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Type of Device
DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key19193951
MDR Text Key341172273
Report Number2124215-2024-25414
Device Sequence Number1
Product Code DRE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K220414
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 04/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/26/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/08/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Death; Life Threatening;
Patient Age76 YR
Patient SexMale
Patient RaceWhite
-
-